Table of Content

  1. INTRODUCTION
    1. Study Assumptions and Market Definition
    2. Scope of the Study
  2. RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
  4. MARKET DYNAMICS
    1. Market Overview
    2. Market Drivers
      1. Advancements in AI and Machine Learning Technologies
    3. Market Restraints
      1. Data Privacy and Security Concerns
      2. High Implementation Costs and Technical Complexity
    4. Market Opportunity
      1. Growing Adoption of Medical Imaging Analysis
    5. Market Trends
      1. Integration of AI with Telemedicine
      2. Development of Personalized Medicine
  5. MARKET SEGMENTATION
    1. By Application
      1. Personalized Treatment
      2. Patient Assistance
      3. Patient Monitoring and Predictive Analytics
      4. Medical Image Analysis and Diagnostics
      5. Drug Discovery and Development
    2. By End user
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers (ASCs)
      4. Research and Academic Institutes
      5. Others
    3. By Key Geographic Regions
      1. North America
        1. United States
        2. Canada
        3. Mexico
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      3. Asia Pacific
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
      4. Middle East and Africa
        1. GCC
        2. South Africa
        3. Rest of Middle East and Africa
      5. South America
        1. Brazil
        2. Argentina
        3. Rest of South America
  6. COMPETITIVE LANDSCAPE
    1. Company Profile
      1. Abridge AI, Inc. (U.S.)
      2. DiagnaMed Holdings Corp. (U.S.)
      3. Epic Systems Corporation (U.S.)
      4. ELEKS (Estonia)
      5. Google LLC (U.S.)
      6. Insilico Medicine (U.S.)
      7. Merative (U.S.)
      8. Microsoft (U.S.)
      9. NVIDIA Corporation (U.S.)
      10. Oracle (U.S.)
      11. Persistent Systems (India)
      12. Syntegra (U.S.)

7. MARKET OPPORTUNITIES AND FUTURE TRENDS



Frequently Asked Questions

Q.1. What is the projected market value of the global Generative AI in Healthcare market?

The global market of Generative AI in Healthcare is projected to reach USD 27.3 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Generative AI in Healthcare market?

The global Generative AI in Healthcare market has an estimated annual growth rate of 32.0%.

Q.3. What are the recent trends of Generative AI in Healthcare market?

Integration of AI with telemedicine and development of personalized medicineare some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Generative AI in Healthcare?

The major companies profiled in this report include Abridge AI, Inc. (U.S.), DiagnaMed Holdings Corp. (U.S.), Epic Systems Corporation (U.S.), ELEKS (Estonia), Google LLC (U.S.), Insilico Medicine (U.S.), Merative (U.S.), Microsoft (U.S.), NVIDIA Corporation (U.S.), Oracle (U.S.), Persistent Systems (India), Syntegra (U.S.), among others.

Q.5. Which is the largest regional market in the Generative AI in Healthcare?

North America is the largest regional market for Generative AI in Healthcare.

 

 

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.